Resveratrol–zinc combination for prostate cancer management

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11 - 30; http://dx.doi.org/10.3322/caac.21166; PMID: 23335087
   PubMed Web of Science ®Google Scholar
• Kelleher SL, McCormick NH, Velasquez V, Lopez V. Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland. Adv Nutr 2011; 2:101 - 11; http://dx.doi.org/10.3945/an.110.000232; PMID: 22332039
   PubMed Web of Science ®Google Scholar
• Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME. Zinc and human health: an update. Arch Toxicol 2012; 86:521 - 34; http://dx.doi.org/10.1007/s00204-011-0775-1; PMID: 22071549
   PubMed Web of Science ®Google Scholar
• Puca R, Nardinocchi L, Porru M, Simon AJ, Rechavi G, Leonetti C, Givol D, D’Orazi G. Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs. Cell Cycle 2011; 10:1679 - 89; http://dx.doi.org/10.4161/cc.10.10.15642; PMID: 21508668
   PubMed Web of Science ®Google Scholar
• Norelli G, Bossi G. Zinc, a promising mineral for misfolded p53 reactivation. Cell Cycle 2011; 10:2415 - 6; http://dx.doi.org/10.4161/cc.10.15.15931; PMID: 21734452
   PubMed Web of Science ®Google Scholar
• D’Orazi G, Givol D. p53 reactivation: the link to zinc. Cell Cycle 2012; 11:2581 - 2; http://dx.doi.org/10.4161/cc.21020; PMID: 22751437
   PubMed Web of Science ®Google Scholar
• Morita A, Ariyasu S, Ohya S, Takahashi I, Wang B, Tanaka K, Uchida T, Okazaki H, Hanaya K, Enomoto A, et al. Evaluation of zinc (II) chelators for inhibiting p53-mediated apoptosis. Oncotarget 2013; 4:2439 - 50; PMID: 24280450
   PubMed Web of Science ®Google Scholar
• Spina R, Filocamo G, Iaccino E, Scicchitano S, Lupia M, Chiarella E, Mega T, Bernaudo F, Pelaggi D, Mesuraca M, et al. Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells. Oncotarget 2013; 4:1280 - 92; PMID: 23907569
   PubMed Web of Science ®Google Scholar
• Sheffer M, Simon AJ, Jacob-Hirsch J, Rechavi G, Domany E, Givol D, D’Orazi G. Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation. Oncotarget 2011; 2:1191 - 202; PMID: 22202117
   PubMed Web of Science ®Google Scholar
• Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 2006; 5:17; http://dx.doi.org/10.1186/1476-4598-5-17; PMID: 16700911
   PubMed Web of Science ®Google Scholar
• Costello LC, Franklin RB. Zinc is decreased in prostate cancer: an established relationship of prostate cancer!. J Biol Inorg Chem 2011; 16:3 - 8; http://dx.doi.org/10.1007/s00775-010-0736-9; PMID: 21140181
   PubMed Web of Science ®Google Scholar
• Zaichick VYe, Sviridova TV, Zaichick SV. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 1997; 29:565 - 74; http://dx.doi.org/10.1007/BF02552202; PMID: 9413764
   PubMedGoogle Scholar
• Franklin RB, Feng P, Milon B, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer 2005; 4:32; http://dx.doi.org/10.1186/1476-4598-4-32; PMID: 16153295
   PubMed Web of Science ®Google Scholar
• Desouki MM, Geradts J, Milon B, Franklin RB, Costello LC. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Mol Cancer 2007; 6:37; http://dx.doi.org/10.1186/1476-4598-6-37; PMID: 17550612
   PubMed Web of Science ®Google Scholar
• Chen QG, Zhang Z, Yang Q, Shan GY, Yu XY, Kong CZ. The role of zinc transporter ZIP4 in prostate carcinoma. Urol Oncol 2012; 30:906 - 11; http://dx.doi.org/10.1016/j.urolonc.2010.11.010; PMID: 21803616
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Wu M, Schoene NW, Cheng W-H, Wang TTY, Alshatwi AA, Alsaif M, Lei KY. Effect of resveratrol and zinc on intracellular zinc status in normal human prostate epithelial cells. Am J Physiol Cell Physiol 2009; 297:C632 - 44; http://dx.doi.org/10.1152/ajpcell.00139.2009; PMID: 19553565
   PubMedGoogle Scholar
• Wagner SE, Burch JB, Hussey J, Temples T, Bolick-Aldrich S, Mosley-Broughton C, Liu Y, Hebert JR. Soil zinc content, groundwater usage, and prostate cancer incidence in South Carolina. Cancer Causes Control 2009; 20:345 - 53; http://dx.doi.org/10.1007/s10552-008-9248-0; PMID: 18949566
   PubMed Web of Science ®Google Scholar
• Costello LC, Franklin RB. Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity. Expert Rev Anticancer Ther 2012; 12:121 - 8; http://dx.doi.org/10.1586/era.11.190; PMID: 22149438
   PubMed Web of Science ®Google Scholar
• Kolenko V, Teper E, Kutikov A, Uzzo R. Zinc and zinc transporters in prostate carcinogenesis. Nat Rev Urol 2013; 10:219 - 26; http://dx.doi.org/10.1038/nrurol.2013.43; PMID: 23478540
   PubMed Web of Science ®Google Scholar
• Epstein MM, Kasperzyk JL, Andrén O, Giovannucci EL, Wolk A, Håkansson N, Andersson SO, Johansson JE, Fall K, Mucci LA. Dietary zinc and prostate cancer survival in a Swedish cohort. Am J Clin Nutr 2011; 93:586 - 93; http://dx.doi.org/10.3945/ajcn.110.004804; PMID: 21228268
   PubMed Web of Science ®Google Scholar
• Gonzalez A, Peters U, Lampe JW, White E. Zinc intake from supplements and diet and prostate cancer. Nutr Cancer 2009; 61:206 - 15; http://dx.doi.org/10.1080/01635580802419749; PMID: 19235036
   PubMed Web of Science ®Google Scholar
• Gallus S, Foschi R, Negri E, Talamini R, Franceschi S, Montella M, Ramazzotti V, Tavani A, Dal Maso L, La Vecchia C. Dietary zinc and prostate cancer risk: a case-control study from Italy. Eur Urol 2007; 52:1052 - 6; http://dx.doi.org/10.1016/j.eururo.2007.01.094; PMID: 17292532
   PubMed Web of Science ®Google Scholar
• Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 2003; 95:1004 - 7; http://dx.doi.org/10.1093/jnci/95.13.1004; PMID: 12837837
   PubMed Web of Science ®Google Scholar
• Costello LC, Franklin RB, Tan MT. A Critical Assessment of Epidemiology Studies Regarding Dietary/Supplemental Zinc and Prostate Cancer Risk. Open Urol Nephrol J 2008; 1; http://dx.doi.org/10.2174/1874303X00801010026; PMID: 24204440
   PubMedGoogle Scholar
• Rishi I, Baidouri H, Abbasi JA, Bullard-Dillard R, Kajdacsy-Balla A, Pestaner JP, Skacel M, Tubbs R, Bagasra O. Prostate cancer in African American men is associated with downregulation of zinc transporters. Appl Immunohistochem Mol Morphol 2003; 11:253 - 60; http://dx.doi.org/10.1097/00129039-200309000-00009; PMID: 12966353
   PubMedGoogle Scholar
• NIH. . The Office of Dietary Supplements (ODS) [ods.od.nih.gov/factsheets/Zinc-HealthProfessional/]
   Google Scholar
• Trumbo P, Yates AA, Schlicker S, Poos M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 2001; 101:294 - 301; http://dx.doi.org/10.1016/S0002-8223(01)00078-5; PMID: 11269606
   PubMed Web of Science ®Google Scholar
• Liang J-H, Liu Y-Y, Franklin RB, Costello LC, Feng P. Inhibitrory effet of zinc on human prostatic carcinoma cell growth. Prostate 1999; 40:200 - 7
   PubMed Web of Science ®Google Scholar
• Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N, Kolenko VM. Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents. Clin Cancer Res 2002; 8:3579 - 83; PMID: 12429649
   PubMed Web of Science ®Google Scholar
• Wong P-F, Abubakar S. Comparative transcriptional study of the effects of high intracellular zinc on prostate carcinoma cells. Oncol Rep 2010; 23:1501 - 16; PMID: 20428803
   PubMed Web of Science ®Google Scholar
• Prasad AS, Mukhtar H, Beck FW, Adhami VM, Siddiqui IA, Din M, Hafeez BB, Kucuk O. Dietary zinc and prostate cancer in the TRAMP mouse model. J Med Food 2010; 13:70 - 6; http://dx.doi.org/10.1089/jmf.2009.0042; PMID: 20136438
   PubMed Web of Science ®Google Scholar
• Shah MR, Kriedt CL, Lents NH, Hoyer MK, Jamaluddin N, Klein C, Baldassare J. Direct intra-tumoral injection of zinc-acetate halts tumor growth in a xenograft model of prostate cancer. J Exp Clin Cancer Res 2009; 28:84; http://dx.doi.org/10.1186/1756-9966-28-84; PMID: 19534805
   PubMed Web of Science ®Google Scholar
• Murakami M, Hirano T. Intracellular zinc homeostasis and zinc signaling. Cancer Sci 2008; 99:1515 - 22; http://dx.doi.org/10.1111/j.1349-7006.2008.00854.x; PMID: 18754861
   PubMed Web of Science ®Google Scholar
• Franklin RB, Milon B, Feng P, Costello LC. Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer. Front Biosci 2005; 10:2230 - 9; http://dx.doi.org/10.2741/1692; PMID: 15970489
   PubMed Web of Science ®Google Scholar
• Franklin RB, Ma J, Zou J, Guan Z, Kukoyi BI, Feng P, Costello LC. Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J Inorg Biochem 2003; 96:435 - 42; http://dx.doi.org/10.1016/S0162-0134(03)00249-6; PMID: 12888280
   PubMed Web of Science ®Google Scholar
• Huang L, Tepaamorndech S. The SLC30 family of zinc transporters - a review of current understanding of their biological and pathophysiological roles. Mol Aspects Med 2013; 34:548 - 60; http://dx.doi.org/10.1016/j.mam.2012.05.008; PMID: 23506888
   PubMed Web of Science ®Google Scholar
• Johnson LA, Kanak MA, Kajdacsy-Balla A, Pestaner JP, Bagasra O. Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands. Methods 2010; 52:316 - 21; http://dx.doi.org/10.1016/j.ymeth.2010.08.004; PMID: 20705137
   PubMed Web of Science ®Google Scholar
• Cui X, Zhang Y, Yang J, Sun X, Hagan JP, Guha S, Li M. ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer. Cell Cycle 2014; 13:1180 - 6; http://dx.doi.org/10.4161/cc.28111; PMID: 24553114
   PubMed Web of Science ®Google Scholar
• Cousins RJ. Gastrointestinal factors influencing zinc absorption and homeostasis. Int J Vitam Nutr Res 2010; 80:243 - 8; http://dx.doi.org/10.1024/0300-9831/a000030; PMID: 21462106
   PubMed Web of Science ®Google Scholar
• Wang F, Kim BE, Petris MJ, Eide DJ. The mammalian Zip5 protein is a zinc transporter that localizes to the basolateral surface of polarized cells. J Biol Chem 2004; 279:51433 - 41; http://dx.doi.org/10.1074/jbc.M408361200; PMID: 15322118
   PubMed Web of Science ®Google Scholar
• Lopez V, Kelleher SL. Zip6-attenuation promotes epithelial-to-mesenchymal transition in ductal breast tumor (T47D) cells. Exp Cell Res 2010; 316:366 - 75; http://dx.doi.org/10.1016/j.yexcr.2009.10.011; PMID: 19852955
   PubMed Web of Science ®Google Scholar
• Huang L, Kirschke CP, Zhang Y, Yu YY. The ZIP7 gene (Slc39a7) encodes a zinc transporter involved in zinc homeostasis of the Golgi apparatus. J Biol Chem 2005; 280:15456 - 63; http://dx.doi.org/10.1074/jbc.M412188200; PMID: 15705588
   PubMed Web of Science ®Google Scholar
• Hogstrand C, Kille P, Nicholson RI, Taylor KM. Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation. Trends Mol Med 2009; 15:101 - 11; http://dx.doi.org/10.1016/j.molmed.2009.01.004; PMID: 19246244
   PubMed Web of Science ®Google Scholar
• Wang CY, Jenkitkasemwong S, Duarte S, Sparkman BK, Shawki A, Mackenzie B, Knutson MD. ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading. J Biol Chem 2012; 287:34032 - 43; http://dx.doi.org/10.1074/jbc.M112.367284; PMID: 22898811
   PubMed Web of Science ®Google Scholar
• Jenkitkasemwong S, Wang CY, Mackenzie B, Knutson MD. Physiologic implications of metal-ion transport by ZIP14 and ZIP8. Biometals 2012; 25:643 - 55; http://dx.doi.org/10.1007/s10534-012-9526-x; PMID: 22318508
   PubMed Web of Science ®Google Scholar
• Taniguchi M, Fukunaka A, Hagihara M, Watanabe K, Kamino S, Kambe T, Enomoto S, Hiromura M. Essential role of the zinc transporter ZIP9/SLC39A9 in regulating the activations of Akt and Erk in B-cell receptor signaling pathway in DT40 cells. PLoS One 2013; 8:e58022; http://dx.doi.org/10.1371/journal.pone.0058022; PMID: 23505453
   PubMedGoogle Scholar
• Kagara N, Tanaka N, Noguchi S, Hirano T. Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells. Cancer Sci 2007; 98:692 - 7; http://dx.doi.org/10.1111/j.1349-7006.2007.00446.x; PMID: 17359283
   PubMed Web of Science ®Google Scholar
• Yu Y, Wu A, Zhang Z, Yan G, Zhang F, Zhang L, Shen X, Hu R, Zhang Y, Zhang K, et al. Characterization of the GufA subfamily member SLC39A11/Zip11 as a zinc transporter. J Nutr Biochem 2013; 24:1697 - 708; http://dx.doi.org/10.1016/j.jnutbio.2013.02.010; PMID: 23643525
   PubMed Web of Science ®Google Scholar
• Chowanadisai W, Graham DM, Keen CL, Rucker RB, Messerli MA. Neurulation and neurite extension require the zinc transporter ZIP12 (slc39a12). Proc Natl Acad Sci U S A 2013; 110:9903 - 8; http://dx.doi.org/10.1073/pnas.1222142110; PMID: 23716681
   PubMed Web of Science ®Google Scholar
• Jeong J, Walker JM, Wang F, Park JG, Palmer AE, Giunta C, Rohrbach M, Steinmann B, Eide DJ. Promotion of vesicular zinc efflux by ZIP13 and its implications for spondylocheiro dysplastic Ehlers-Danlos syndrome. Proc Natl Acad Sci U S A 2012; 109:E3530 - 8; http://dx.doi.org/10.1073/pnas.1211775110; PMID: 23213233
   PubMed Web of Science ®Google Scholar
• Franklin RB, Levy BA, Zou J, Hanna N, Desouki MM, Bagasra O, Johnson LA, Costello LC. ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer. J Gastrointest Cancer 2012; 43:249 - 57; http://dx.doi.org/10.1007/s12029-011-9269-x; PMID: 21373779
   PubMedGoogle Scholar
• Urani C, Melchioretto P, Gribaldo L. Regulation of metallothioneins and ZnT-1 transporter expression in human hepatoma cells HepG2 exposed to zinc and cadmium. Toxicol In Vitro 2010; 24:370 - 4; http://dx.doi.org/10.1016/j.tiv.2009.11.003; PMID: 19900532
   PubMed Web of Science ®Google Scholar
• Hasumi M, Suzuki K, Matsui H, Koike H, Ito K, Yamanaka H. Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Lett 2003; 200:187 - 95; http://dx.doi.org/10.1016/S0304-3835(03)00441-5; PMID: 14568174
   PubMed Web of Science ®Google Scholar
• Song Y, Elias V, Wong CP, Scrimgeour AG, Ho E. Zinc transporter expression profiles in the rat prostate following alterations in dietary zinc. Biometals 2010; 23:51 - 8; http://dx.doi.org/10.1007/s10534-009-9266-8; PMID: 19760107
   PubMed Web of Science ®Google Scholar
• Smidt K, Rungby J. ZnT3: a zinc transporter active in several organs. Biometals 2012; 25:1 - 8; http://dx.doi.org/10.1007/s10534-011-9490-x; PMID: 21866305
   PubMed Web of Science ®Google Scholar
• Beck FW, Prasad AS, Butler CE, Sakr WA, Kucuk O, Sarkar FH. Differential expression of hZnT-4 in human prostate tissues. Prostate 2004; 58:374 - 81; http://dx.doi.org/10.1002/pros.10344; PMID: 14968438
   PubMed Web of Science ®Google Scholar
• Coneyworth LJ, Mathers JC, Ford D. Does promoter methylation of the SLC30A5 (ZnT5) zinc transporter gene contribute to the ageing-related decline in zinc status?. Proc Nutr Soc 2009; 68:142 - 7; http://dx.doi.org/10.1017/S0029665109001104; PMID: 19245740
   PubMed Web of Science ®Google Scholar
• Huang L, Kirschke CP, Gitschier J. Functional characterization of a novel mammalian zinc transporter, ZnT6. J Biol Chem 2002; 277:26389 - 95; http://dx.doi.org/10.1074/jbc.M200462200; PMID: 11997387
   PubMed Web of Science ®Google Scholar
• Tepaamorndech S, Huang L, Kirschke CP. A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model. Cancer Lett 2011; 308:33 - 42; http://dx.doi.org/10.1016/j.canlet.2011.04.011; PMID: 21621325
   PubMed Web of Science ®Google Scholar
• Lefebvre B, Vandewalle B, Balavoine AS, Queniat G, Moerman E, Vantyghem MC, Le Bacquer O, Gmyr V, Pawlowski V, Kerr-Conte J, et al. Regulation and functional effects of ZNT8 in human pancreatic islets. J Endocrinol 2012; 214:225 - 32; http://dx.doi.org/10.1530/JOE-12-0071; PMID: 22582094
   PubMed Web of Science ®Google Scholar
• Overbeck S, Uciechowski P, Ackland ML, Ford D, Rink L. Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9. J Leukoc Biol 2008; 83:368 - 80; http://dx.doi.org/10.1189/jlb.0307148; PMID: 17971500
   PubMed Web of Science ®Google Scholar
• Bosomworth HJ, Thornton JK, Coneyworth LJ, Ford D, Valentine RA. Efflux function, tissue-specific expression and intracellular trafficking of the Zn transporter ZnT10 indicate roles in adult Zn homeostasis. Metallomics 2012; 4:771 - 9; http://dx.doi.org/10.1039/c2mt20088k; PMID: 22706290
   PubMed Web of Science ®Google Scholar
• Zhang S, Qian X, Redman C, Bliskovski V, Ramsay ES, Lowy DR, Mock BA. p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene 2003; 22:2285 - 95; http://dx.doi.org/10.1038/sj.onc.1206257; PMID: 12700664
   PubMed Web of Science ®Google Scholar
• Milon BC, Agyapong A, Bautista R, Costello LC, Franklin RB. Ras responsive element binding protein-1 (RREB-1) down-regulates hZIP1 expression in prostate cancer cells. Prostate 2010; 70:288 - 96; PMID: 19802870
   PubMed Web of Science ®Google Scholar
• Zou J, Milon BC, Desouki MM, Costello LC, Franklin RB. hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1). Prostate 2011; 71:1518 - 24; PMID: 21360563
   PubMed Web of Science ®Google Scholar
• Vašák M, Meloni G. Chemistry and biology of mammalian metallothioneins. J Biol Inorg Chem 2011; 16:1067 - 78; http://dx.doi.org/10.1007/s00775-011-0799-2; PMID: 21647776
   PubMed Web of Science ®Google Scholar
• Wei H, Desouki MM, Lin S, Xiao D, Franklin RB, Feng P. Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues. Mol Cancer 2008; 7:7; http://dx.doi.org/10.1186/1476-4598-7-7; PMID: 18208603
   PubMed Web of Science ®Google Scholar
• Hadler-Olsen E, Winberg JO, Uhlin-Hansen L. Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol 2013; 34:2041 - 51; http://dx.doi.org/10.1007/s13277-013-0842-8; PMID: 23681802
   PubMed Web of Science ®Google Scholar
• Ozden F, Saygin C, Uzunaslan D, Onal B, Durak H, Aki H. Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival. J Cancer Res Clin Oncol 2013; 139:1373 - 82; http://dx.doi.org/10.1007/s00432-013-1453-x; PMID: 23708302
   PubMed Web of Science ®Google Scholar
• Makhov PB, Golovine KV, Kutikov A, Canter DJ, Rybko VA, Roshchin DA, Matveev VB, Uzzo RG, Kolenko VM. Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells. Carcinogenesis 2011; 32:1773 - 81; http://dx.doi.org/10.1093/carcin/bgr212; PMID: 21940908
   PubMed Web of Science ®Google Scholar
• Cucciolla V, Borriello A, Oliva A, Galletti P, Zappia V, Della Ragione F. Resveratrol: from basic science to the clinic. Cell Cycle 2007; 6:2495 - 510; http://dx.doi.org/10.4161/cc.6.20.4815; PMID: 17726376
   PubMed Web of Science ®Google Scholar
• Pervaiz S, Holme AL. Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 2009; 11:2851 - 97; http://dx.doi.org/10.1089/ars.2008.2412; PMID: 19432534
   PubMed Web of Science ®Google Scholar
• Harikumar KB, Aggarwal BB. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008; 7:1020 - 35; http://dx.doi.org/10.4161/cc.7.8.5740; PMID: 18414053
   PubMed Web of Science ®Google Scholar
• Valenzano DR, Cellerino A. Resveratrol and the pharmacology of aging: a new vertebrate model to validate an old molecule. Cell Cycle 2006; 5:1027 - 32; http://dx.doi.org/10.4161/cc.5.10.2739; PMID: 16687936
   PubMed Web of Science ®Google Scholar
• Jasiński M, Jasińska L, Ogrodowczyk M. Resveratrol in prostate diseases - a short review. Cent European J Urol 2013; 66:144 - 9; PMID: 24579014
   PubMedGoogle Scholar
• Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther 2006; 5:1335 - 41; http://dx.doi.org/10.1158/1535-7163.MCT-05-0526; PMID: 16731767
   PubMed Web of Science ®Google Scholar
• Baptista T, Graça I, Sousa EJ, Oliveira AI, Costa NR, Costa-Pinheiro P, Amado F, Henrique R, Jerónimo C. Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer. Oncotarget 2013; 4:1673 - 85; PMID: 24127549
   PubMed Web of Science ®Google Scholar
• Yilmaz MI, Saglam K, Sonmez A, Gok DE, Basal S, Kilic S, Akay C, Kocar IH. Antioxidant system activation in prostate cancer. Biol Trace Elem Res 2004; 98:13 - 9; http://dx.doi.org/10.1385/BTER:98:1:13; PMID: 15051896
   PubMed Web of Science ®Google Scholar
• Harper CE, Patel BB, Wang J, Arabshahi A, Eltoum IA, Lamartiniere CA. Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 2007; 28:1946 - 53; http://dx.doi.org/10.1093/carcin/bgm144; PMID: 17675339
   PubMed Web of Science ®Google Scholar
• Seeni A, Takahashi S, Takeshita K, Tang M, Sugiura S, Sato SY, Shirai T. Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac J Cancer Prev 2008; 9:7 - 14; PMID: 18439064
   PubMed Web of Science ®Google Scholar
• Singh CK, George J, Ahmad N. Resveratrol-based combinatorial strategies for cancer management. Ann N Y Acad Sci 2013; 1290:113 - 21; http://dx.doi.org/10.1111/nyas.12160; PMID: 23855473
   PubMed Web of Science ®Google Scholar
• Kavas GO, Aribal-Kocatürk P, Büyükkağnici DI. Resveratrol: is there any effect on healthy subject?. Biol Trace Elem Res 2007; 118:250 - 4; http://dx.doi.org/10.1007/s12011-007-0033-9; PMID: 17916928
   PubMed Web of Science ®Google Scholar
• Dias K, Nikolaou S. Does the combination of resveratrol with Al (III) and Zn (II) improve its antioxidant activity?. Nat Prod Commun 2011; 6:1673 - 6; PMID: 22224286
   PubMed Web of Science ®Google Scholar
• Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 2010; 70:9003 - 11; http://dx.doi.org/10.1158/0008-5472.CAN-10-2364; PMID: 20935227
   PubMed Web of Science ®Google Scholar
• Tompkins TA, Renard NE, Kiuchi A. Clinical evaluation of the bioavailability of zinc-enriched yeast and zinc gluconate in healthy volunteers. Biol Trace Elem Res 2007; 120:28 - 35; http://dx.doi.org/10.1007/s12011-007-0072-2; PMID: 17916952
   PubMed Web of Science ®Google Scholar
• Kahmann L, Uciechowski P, Warmuth S, Plümäkers B, Gressner AM, Malavolta M, Mocchegiani E, Rink L. Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res 2008; 11:227 - 37; http://dx.doi.org/10.1089/rej.2007.0613; PMID: 18279033
   PubMed Web of Science ®Google Scholar
• Huang L, Kirschke CP, Zhang Y. Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int 2006; 6:10; http://dx.doi.org/10.1186/1475-2867-6-10; PMID: 16579854
   PubMed Web of Science ®Google Scholar
• Malhotra A, Nair P, Dhawan DK. Curcumin and resveratrol synergistically stimulate p21 and regulate cox-2 by maintaining adequate zinc levels during lung carcinogenesis. Eur J Cancer Prev 2011; 20:411 - 6; http://dx.doi.org/10.1097/CEJ.0b013e3283481d71; PMID: 21633290
   PubMed Web of Science ®Google Scholar
• Quesada IM, Bustos M, Blay M, Pujadas G, Ardèvol A, Salvadó MJ, Bladé C, Arola L, Fernández-Larrea J. Dietary catechins and procyanidins modulate zinc homeostasis in human HepG2 cells. J Nutr Biochem 2011; 22:153 - 63; http://dx.doi.org/10.1016/j.jnutbio.2009.12.009; PMID: 20471814
   PubMed Web of Science ®Google Scholar
• Sreenivasulu K, Raghu P, Nair KM. Polyphenol-rich beverages enhance zinc uptake and metallothionein expression in Caco-2 cells. J Food Sci 2010; 75:H123 - 8; http://dx.doi.org/10.1111/j.1750-3841.2010.01582.x; PMID: 20546406
   PubMedGoogle Scholar